These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32493170)

  • 21. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial.
    Bristow SM; Gamble GD; Pasch A; O'Neill WC; Stewart A; Horne AM; Reid IR
    Osteoporos Int; 2016 Mar; 27(3):1209-1216. PubMed ID: 26493812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum calcification propensity in type 1 diabetes associates with mineral stress.
    van Dijk PR; Hop H; Waanders F; Mulder UJ; Pasch A; Hillebrands JL; van Goor H; Bilo HJG
    Diabetes Res Clin Pract; 2019 Dec; 158():107917. PubMed ID: 31697993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus.
    Mencke R; van der Vaart A; Pasch A; Harms G; Waanders F; Bilo HJG; van Goor H; Hillebrands JL; van Dijk PR
    BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33627317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.
    Dekker M; Pasch A; van der Sande F; Konings C; Bachtler M; Dionisi M; Meier M; Kooman J; Canaud B
    PLoS One; 2016; 11(4):e0151508. PubMed ID: 27064679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Meer R; Romero Prats ML; Vervloet MG; van der Schouw YT; de Jong PA; Beulens JWJ
    Atherosclerosis; 2024 Jul; 394():117307. PubMed ID: 37852868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propensity for Calcification in Serum Associates With 2-Year Cardiovascular Mortality in Ischemic Heart Failure With Reduced Ejection Fraction.
    Bojic M; Koller L; Cejka D; Niessner A; Bielesz B
    Front Med (Lausanne); 2021; 8():672348. PubMed ID: 34222283
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcification Propensity of Serum is Independent of Excretory Renal Function.
    Bielesz B; Reiter T; Marculescu R; Gleiss A; Bojic M; Kieweg H; Cejka D
    Sci Rep; 2017 Dec; 7(1):17941. PubMed ID: 29263429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease.
    Silaghi CN; Ilyés T; Van Ballegooijen AJ; Crăciun AM
    J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32365608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism.
    Kantauskaite M; Bolten K; Boschheidgen M; Schmidt C; Kolb T; Eckardt KU; Pasch A; Schimmöller L; Rump LC; Voelkl J; Stegbauer J
    Front Cardiovasc Med; 2022; 9():771096. PubMed ID: 35141300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Shoji T; Nakatani S; Kabata D; Mori K; Shintani A; Yoshida H; Takahashi K; Ota K; Fujii H; Ueda S; Nishi S; Nakatani T; Yoshiyama M; Goto K; Hamada T; Imanishi M; Ishimura E; Kagitani S; Kato Y; Kumeda Y; Maekawa K; Matsumura T; Nagayama H; Obi Y; Ohno Y; Sai Y; Sakurai M; Sasaki S; Shidara K; Shoji S; Tsujimoto Y; Yamakawa K; Yasuda H; Yodoi S; Inaba M; Emoto M
    Clin J Am Soc Nephrol; 2021 Apr; 16(4):599-612. PubMed ID: 33685864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favourable serum calcification propensity with intraperitoneal as compared with subcutaneous insulin administration in type 1 diabetes.
    van Dijk PR; Waanders F; Pasch A; Logtenberg SJJ; Vriesendorp T; Groenier KH; Hillebrands JL; Kleefstra N; Gans ROB; van Goor H; Bilo HJG
    Ther Adv Endocrinol Metab; 2020; 11():2042018820908456. PubMed ID: 32166012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum calcification propensity is associated with renal tissue oxygenation and resistive index in patients with arterial hypertension or chronic kidney disease.
    Pruijm M; Lu Y; Megdiche F; Piskunowicz M; Milani B; Stuber M; Bachtler M; Vogt B; Burnier M; Pasch A
    J Hypertens; 2017 Oct; 35(10):2044-2052. PubMed ID: 28562422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
    Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
    Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential associations of fetuin-A and calcification propensity with cardiovascular events and subsequent mortality in patients undergoing hemodialysis.
    Mori K; Shoji T; Nakatani S; Uedono H; Ochi A; Yoshida H; Imanishi Y; Morioka T; Tsujimoto Y; Kuro-O M; Emoto M
    Clin Kidney J; 2024 Mar; 17(3):sfae042. PubMed ID: 38487079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid and sustained improvement of calcification propensity score (serum T
    Smerud KT; Åsberg A; Kile H; Pasch A; Dahle DO; Bollerslev J; Godang K; Hartmann A
    Clin Transplant; 2017 Dec; 31(12):. PubMed ID: 28972673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community.
    Larsson TE; Olauson H; Hagström E; Ingelsson E; Arnlöv J; Lind L; Sundström J
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):333-9. PubMed ID: 19948843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
    Fenton A; Chinnadurai R; Gullapudi L; Kampanis P; Dasgupta I; Ritchie J; Harding S; Ferro CJ; Kalra PA; Taal MW; Cockwell P
    PLoS Med; 2020 Feb; 17(2):e1003050. PubMed ID: 32109242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum magnesium and cardiovascular mortality in peritoneal dialysis patients: a 5-year prospective cohort study.
    Ye H; Cao P; Zhang X; Lin J; Guo Q; Mao H; Yu X; Yang X
    Br J Nutr; 2018 Aug; 120(4):415-423. PubMed ID: 30022737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.